Baden-Württemberg’s location in the centre of Europe offers a significant advantage in that it guarantees access to many important markets. Medical technology companies in Baden-Württemberg develop and produce technologically high-quality products and are therefore leading players in Germany and Europe. Their products enjoy high national and international demand and are used throughout the world.
Medical technology in Germany
-
Germany is the largest market for medical technology in Europe with a share of 35% and is the third largest in the world.
-
In Germany around 160,000 people are employed in more than 11,000 enterprises in the core areas of the sector.
-
The volume of sales in the medical technology sector has risen more strongly than the economy as a whole, with an annual increase in sales of 7% between 1995 and 2007. By 2015 a further increase in sales of 7% p.a. is forecast.
-
In terms of exports, Germany has a share in the world market of around 15%, lying behind the USA (31%) but significantly ahead of Japan, which is in second place with around 6% worldwide. Exports of medical technology products are higher than for industry overall, with a share of 64%. The export figure in general is around 44%.
-
The German medical technology sector is one of the most innovative sectors in the state. With around 17,000 patent applications, medical technology has the highest number of such applications and, at around 12%, accounts for the highest number of technical applications in Germany. Worldwide, Germany lies in second place after the USA in terms of patent applications.
-
German medical technology manufacturers generate around one third of their turnover with products which are at most three years old, thereby underlining the dynamic and highly innovative development of the sector.
-
On average, businesses in the medical technology sector invest around 9% of their turnover in research and development. By way of comparison, expenditure on research and development in the manufacturing industry is on average less than 5%.